Vanja Lazarevic, Ph.D. - Publications

2005 University of Pittsburgh, Pittsburgh, PA, United States 
Immunology, Cell Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Adoro S, Cubillos-Ruiz JR, Chen X, Deruaz M, Vrbanac VD, Song M, Park S, Murooka TT, Dudek TE, Luster AD, Tager AM, Streeck H, Bowman B, Walker BD, Kwon DS, ... Lazarevic V, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nature Communications. 6: 7562. PMID 26108174 DOI: 10.1038/ncomms8562  0.64
2014 Kwong B, Lazarevic V. T-bet orchestrates CD8αα IEL differentiation. Immunity. 41: 169-71. PMID 25148017 DOI: 10.1016/j.immuni.2014.08.003  0.64
2014 Hong C, Luckey MA, Ligons DL, Waickman AT, Park JY, Kim GY, Keller HR, Etzensperger R, Tai X, Lazarevic V, Feigenbaum L, Catalfamo M, Walsh STR, Park JH. Activated T Cells Secrete an Alternatively Spliced Form of Common γ-Chain that Inhibits Cytokine Signaling and Exacerbates Inflammation Immunity. 40: 910-923. PMID 24909888 DOI: 10.1016/j.immuni.2014.04.020  0.64
2014 Wang Y, Godec J, Ben-Aissa K, Cui K, Zhao K, Pucsek AB, Lee YK, Weaver CT, Yagi R, Lazarevic V. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells. Immunity. 40: 355-66. PMID 24530058 DOI: 10.1016/j.immuni.2014.01.002  0.64
2013 Lazarevic V, Glimcher LH, Lord GM. T-bet: A bridge between innate and adaptive immunity Nature Reviews Immunology. 13: 777-789. PMID 24113868 DOI: 10.1038/nri3536  0.64
2012 Wein MN, Jones DC, Shim JH, Aliprantis AO, Sulyanto R, Lazarevic V, Poliachik SL, Gross TS, Glimcher LH. Control of bone resorption in mice by Schnurri-3. Proceedings of the National Academy of Sciences of the United States of America. 109: 8173-8. PMID 22573816 DOI: 10.1073/pnas.1205848109  0.64
2011 Lazarevic V, Glimcher LH. T-bet in disease. Nature Immunology. 12: 597-606. PMID 21685955 DOI: 10.1038/ni.2059  0.64
2011 Staton TL, Lazarevic V, Jones DC, Lanser AJ, Takagi T, Ishii S, Glimcher LH. Dampening of death pathways by schnurri-2 is essential for T-cell development. Nature. 472: 105-9. PMID 21475200 DOI: 10.1038/nature09848  0.64
2011 Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nature Immunology. 12: 96-104. PMID 21151104 DOI: 10.1038/ni.1969  0.64
2010 Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS, Croxford A, Waisman A, Kuchroo VK, Glimcher LH, Oukka M. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. Journal of Immunology (Baltimore, Md. : 1950). 184: 1710-20. PMID 20083652 DOI: 10.4049/jimmunol.0902796  0.64
2009 Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, Glimcher LH. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nature Immunology. 10: 306-13. PMID 19169262 DOI: 10.1038/ni.1696  0.64
2008 Lazarevic V, Martinon F. Linking inflammasome activation and phagosome maturation. Cell Host & Microbe. 3: 199-200. PMID 18407061 DOI: 10.1016/j.chom.2008.03.006  0.64
2005 Sullivan BM, Jobe O, Lazarevic V, Vasquez K, Bronson R, Glimcher LH, Kramnik I. Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production. Journal of Immunology (Baltimore, Md. : 1950). 175: 4593-602. PMID 16177104 DOI: 10.4049/jimmunol.175.7.4593  0.64
2005 Lazarevic V, Nolt D, Flynn JL. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. Journal of Immunology (Baltimore, Md. : 1950). 175: 1107-17. PMID 16002712  0.64
2005 Lazarevic V, Pawar S, Flynn J. Measuring T-cell function in animal models of tuberculosis by ELISPOT. Methods in Molecular Biology (Clifton, N.J.). 302: 179-90. PMID 15937352 DOI: 10.1385/1-59259-903-6:179  0.64
2005 Lazarevic V, Yankura DJ, DiVito SJ, Flynn JL. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infection and Immunity. 73: 2910-22. PMID 15845497 DOI: 10.1128/IAI.73.5.2910-2922.2005  0.64
2005 Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrobial Agents and Chemotherapy. 49: 316-22. PMID 15616311 DOI: 10.1128/AAC.49.1.316-322.2005  0.64
2003 Lazarevic V, Myers AJ, Scanga CA, Flynn JL. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity. 19: 823-35. PMID 14670300 DOI: 10.1016/S1074-7613(03)00324-8  0.64
2002 Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. American Journal of Respiratory and Critical Care Medicine. 166: 1116-21. PMID 12379557 DOI: 10.1164/rccm.2204027  0.64
2002 Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB, Watkins S, Tencza SB, Vogel HJ, Montelaro RC, Mietzner TA. Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens. Antimicrobial Agents and Chemotherapy. 46: 2041-5. PMID 12019137 DOI: 10.1128/AAC.46.6.2041-2045.2002  0.64
2001 Serbina NV, Lazarevic V, Flynn JL. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. Journal of Immunology (Baltimore, Md. : 1950). 167: 6991-7000. PMID 11739519  0.64
Show low-probability matches.